News & Publications

Find out the most relevant news on the latest advancements in lung cancer!

NEWS

Another successful World Conference on Lung Cancer (WCLC) for I3LUNG

Barcelona in early September gave us more than late summer sun, tapas, and strolls by the beach, it gave us […]

Arsela Prelaj represents I3LUNG at the WCLC 2025 Scientific Plenary

On the final day of #WCLC25, Arsela Prelaj represented #I3LUNG at the Scientific Plenary with her talk: “Data-Driven oncology: how […]

🚨 Oral sessions are always a highlight at #WCLC2025!

Today, our #I3LUNG project was part of that spotlight as Arsela Prelaj from Fondazione IRCCS Istituto Nazionale dei Tumori di […]

I3LUNG at WCLC2025: Using AI to Predict Immunotherapy Biomarkers

On day 3 of #WCLC2025, Vanja Mišković from Politecnico di Milano presented the study: “An ensemble approach to predict three-class […]

Day 2 at WCLC 2025: Presenting our poster on early lung cancer detection

Today, our PI, Arsela Prelaj, defended our poster “Exploring the potential of multimodal cough analysis as a pre-screening tool for […]

Kicking off #WCLC25: Day 1 highlights from I3LUNG 👏🏼

Today marked the first day of the International Association for the Study of Lung Cancer hashtag#WCLC25 in Barcelona — and […]

Another I3LUNG highlight at WCLC25!

Beyond our posters, oral presentation, and plenary talk, we’re excited to share that Arsela Prelaj, will also take part in […]

Looking ahead to WCLC 2025? I3LUNG will be in action!

The countdown is on, and the I3LUNG team has a full agenda during the International Association for the Study of […]

🤖✨ How is artificial intelligence transforming lung cancer research and treatment?

Dr. Arsela Prelaj, PI of our #I3LUNG project, was invited to the Lung Cancer Considered podcast by International Association for […]

World Lung Cancer Day

Today, we join the global call to raise awareness about lung cancer, one of the world’s leading causes of cancer-related […]

From Sound to Signal: Cough-Based Cancer Detection at #EMBC 2025

🔊 A cough might reveal more than we think… Yesterday at #EMBC 2025 in Copenhagen, Chiara Giangregorio (Politecnico di Milano) […]

❌ AI isn’t here to replace doctors: it’s here to support them.

In this video, Anniina Hentinen from Lung Cancer Europe breaks down what AI really means for patients: 🧠 AI analyzes […]

Tech helps us see the “what.” Psychology helps us ask “why.”

Chiara Giangregorio decodes data patterns. Valeria Sebri brings in the psychological layer. Together, they turn raw data into insights that […]

How do we build artificial intelligence in oncology that is understandable and trustworthy?

Vanja Mišković Miskovic from Politecnico di Milano brought this question to the stage at the AI in Oncology by IHU […]

The Summer School on AI in Cancer Research is still in full swing until Tuesday!

Dr. Raquel Perez-Lopez, one of the co-founders of this initiative, is capturing the dynamic spirit and mission behind the event. […]

What is ESAC – European Interdisciplinary Society of AI for Cancer Research? 🤖🧬

A newly founded multidisciplinary scientific society with one clear mission: to ensure the proper, accurate, and transparent implementation of Artificial […]

The Summer School on AI in Cancer Research kicks off.

The #I3LUNG partners Dr. Helena Linardou, Arsela Prelaj, and Marina Chiara Garassino proudly opened the Summer School on AI in […]

I3LUNG leads the way towards personalized oncology through artificial intelligence

For the third consecutive year, the 16 partners of the I3LUNG consortium, an EU-funded project under the Horizon 2020 programme, […]

Day 2 has wrapped up, and what a ride! 🎢

This year’s meeting has been packed with bold ideas 💡, honest debates 🗣️, and collaborative energy 🤝, all driving us toward a stronger, […]

How cool are the European projects that bring together people from different backgrounds, cultures and languages?!

We’ve lost count of how many languages are spoken across our #I3LUNG Consortium, but one thing’s for sure: collaboration is […]

Catch the energy from our #AnnualMeeting 🇪🇺🫁

Two days a year when we come together, share ideas💡, reconnect 🤝, we remember why we love what we do […]

Artificial Intelligence in Cancer Research – Summer School –

🎓 Get ready for the Artificial Intelligence in Cancer Research Summer School co-organized by HeCOG-Hellenic Cooperative Oncology Group, Metropolitan Hospital, […]

What do artificial intelligence, European health data and precision oncology have in common?

Silvia Flor Arnal, Data Holder Manager at the European Federation for Cancer Images (EUCAIM), will share her insights at the […]

📢 The countdown to the #3LUNG Annual Meeting 2025 is on!

On June 12-13 we will gather in Corfu (Greece) to enjoy two days of collaboration, knowledge and connection. The Annual […]

#ASCO25: Giving Lung Cancer a New Voice with AI and Acoustic Biomarkers

What if your voice could help detect lung cancer? 🫁 That’s the question Chiara Giangregorio of Politecnico di Milano asked […]

I3LUNG at ASCO 2025 🚀🫁

We’re excited to be attending American Society of Clinical Oncology (ASCO) to share latest advances in NSCLC research! Join us […]

We had great insights in this edition of AI for Oncology!

Wow, that was wild. We had great insights in this edition of AI for Oncology, and we wanted to share […]

👋🏼 Hello everyone, greetings from AI for oncology 2025!

The event is well underway, bringing together leading experts, researchers, and innovators to explore the latest in AI-driven cancer care. […]

📢 I3LUNG was present at the Annual Meeting of the American Association for Cancer Research (#AACR2025), held from May 25 to 30 in Chicago.

Dr. Sabina Sangaletti from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano presented the poster “Unmasking host immune complexity: single-cell […]

Why is AI for Oncology an essential event for cancer research and patient care?

Arsela Prelaj, President of the 3rd edition of the AI for Oncology Congress and Medical Oncologist at the Fondazione IRCCS […]

📣 REGISTRATION IS OPEN! Discover the power of #AI in oncology – 3rd edition!

The I3LUNG project, led by Principal Investigator Arsela Prelaj, invites you to an unmissable event where global experts will explore […]

Paris, ELCC 2025

From March 26 to 29, the European Lung Cancer Congress brought together international leaders in thoracic oncology, and we are […]

World Health Day

This WorldHealthDay, we join the World Health Organization in its initiative, “Healthy Beginnings, Hopeful futures“, which highlights the importance of […]

Did you know about #ESAC? Of course not, because it’s brand new! 🚀

We’re excited to share that some of our #I3LUNG partners, Arsela Prelaj, Helena Linardou, Giovanni Scoazec and Vanja Mišković, have […]

Can IA revolutionize healthcare without losing sight of people?

On February 10th, Alessandra Pedrocchi from Politecnico di Milano represented the I3LUNG project at Canova Club, exploring the role of […]

World Cancer Day 2025: Showcasing I3LUNG at the HADEA Cancer Event

On February 4th, 2025—World Cancer Day—the European Health and Digital Executive Agency (HaDEA) hosted a landmark event in Brussels, bringing […]

World Cancer Day

Lungs don’t speak, but they tell a story. Every breath holds a secret of resilience, of science pushing forward, of […]

AI is not the future, it’s the present of lung cancer

On January 31st and February 1st, Dr. Arsela Prelaj, (PI) of the I3LUNG project, took the conversation to the next […]

Empowering lung cancer patients with decision aids, by our partner IEO

· Decision aids enhance shared decision-making, reduce anxiety, and improve understanding of treatment options. · Patients value personalized support and […]

The Patient’s Voice in the Digital Era: Yvonne Díaz, Advocate for Lung Cancer Europe, at Upsmart 2024

As part of the I3LUNG project, we highlight the inspiring presentation by Yvonne Díaz, patient advocate and member of Lung […]

2025: We are starting strong!

Our manuscript “Cost-effectiveness models of non–small cell lung cancer: A systematic literature review” is now available in the Journal of […]

I3LUNG showcased as a use case at the AI X Oncologia Hackathon by Humanitas Research Hospital & Microsoft in Milan

The Hackathon had the objective of setting up collaborative groups, having them come up with innovative, AI-driven approaches to combat […]

Gold for I3LUNG and the Metropolitan Hospital

The I3LUNG project and the Metropolitan Hospital have been awarded the Gold Prize at the prestigious Healthcare Business Awards, recognizing […]

VIII Thoracic Oncology Conference with Arsela Prelaj

At the recent VIII Thoracic Oncology Conference in Bari, the I3LUNG project PI, Arsela Prelaj, took the stage with her […]

ISPOR 2024

Michael Willis, from the IHE – The Swedish Institute for Health Economics attended the 2024ISPOR conference in Barcelona this week […]

I3LUNG Partners Meet at MEDSIR’s Office

Last Friday, MEDSIR’s office hosted a meeting for the I3LUNG partners: Vall d’Hebron Institute of Oncology (VHIO), Universitätsklinikum Hamburg Eppendorf, […]

Great insights at the ” ESMO Molecular Analysis for Precision Oncology Congress 2024 ” in London!

During the session on “Ethical and Regulatory Aspects for Implementing AI in Clinical Trials,” Arsela Prelaj, our I3LUNG partner from Fondazione IRCCS Istituto […]

I3LUNG participates in Cancer Core Europe’s summer with AI-Powered Oncology solutions

I3LUNG made an appearance at “Cancer Core Europe’s Summer School in Translational Cancer Research 2024”, in Albufeira (Portugal). On October 9, […]

Exploring AI’s Role in Cancer Research: I3LUNG at Building Bridges 2024

Arsela Prelaj has presented I3LUNG project during the “Building Bridges to Interconnect People 2024 meeting“, a yearly Italian digital meeting and […]

Artificial Intelligence continues to pave new paths in oncology!

During the 125th Congresso Nazionale di Oncologia, held from October 11th to 13th, Francesco Trovò, from our partner Politecnico di […]

WORLD MENTAL HEALTH DAY

Today, on World Mental Health Day, the I3LUNG project emphasizes the importance of mental health. Since the project’s inception, we […]

I3LUNG at ESMO 2024

I3LUNG was featured at the ESMO – European Society for Medical Oncology, held from September 13 to 17 in Barcelona. […]

MEDSIR Hosts Event on the Future of Breast and Lung Cancer: Insights from a Decade of Research

Last Thursday, 12th of September, MEDSIR organized an insightful event titled “10 Years from Now – The Future of Breast […]

Massimo Broggini Showcases AI-Driven I3LUNG Project in Milan Seminar

Another day, another partner going all out. Massimo Broggini, Head Department of Experimental Oncology, from Istituto Mario Negri participated in […]

IHE present in the Journal of Managed Care & Specialty Pharmacy!

Michael Willis and his team at IHE – The Swedish Institute for Health Economics, have published a groundbreaking article in […]

Here is how the I3LUNG Third Annual Meeting went!

On June 21st and 22nd 2024, under the warm hospitality of the partner Metropolitan Hospital (MH), we celebrated the third […]

I3LUNG project featured in Nature Portfolio!

I3LUNG project has been featured in Nature Portfolio, one of the world’s most prestigious scientific platforms. In this article, Arsela […]

I3LUNG project dissemination at Università di Siena Event

Francesco Trovò from Politecnico di Milano participated in the L’intelligenza artificiale in Sanità event organized by the Università di Siena, […]

Vanja Mišković presents the I3LUNG project at the Scientific Forum of Romanian Young Oncologists

The Scientific Forum of Romanian Young Oncologists was the stage for a notable presentation by Vanja Mišković from Politecnico di […]

The I3LUNG project is presented at the ESMO 2024 Conference

Arsela Prelaj, PI of the I3LUNG project from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, presented our project at […]

We are proud to share our latest study in Cancer Medicine Journal

We are proud to share our latest study in Cancer Medicine journal led by our partner IEO Istituto Europeo di […]

I3LUNG Project: Leveraging Immunotherapy and AI to Revolutionize Lung Cancer Treatment

Lung cancer is known for its aggressiveness. In recent years, new hopes have arisen for patients with the advent of […]

Join us at the I3LUNG Annual Meeting 2023!

On June 30th and July 1st, this year’s I3LUNG Annual Meeting took place at the MEDSIR offices in Barcelona, Spain. […]

Economic Impact Assessment

The Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy (I3LUNG) consortium, funded by Horizon Europe, is […]

European Lung Cancer Congress, highlights of innovative treatments in the era of personalized medicine.

  On 29 of March -1 of April took place the ESMO – European Lung Cancer Congress in Copenhagen, Denmark, […]

Personalized Medicine and the Limitations of Molecular Biomarkers

Cancer is a complex disease caused by mutations in DNA. Over the years, significant progress has been made in understanding […]

The I3LUNG project just published in Clinical Lung Cancer

We are pleased to announce that the study design of the I3LUNG project has just been published in the journal […]

Green light for the European platform for personalized medicine in lung cancer

CONSUMER – Hacia una enfermedad prevenible, curable o crónica. Bio World – A $10M EU initiative launches to develop AI-based […]

Can Artificial Intelligence be used in clinics?

Artificial Intelligence in our daily lives Artificial Intelligence (AI), despite being perceived as something straight out of science fiction, is […]

Lung cancer from a global perspective

Lung cancer Cancer is an omnipresent reality in our lives. It affects countless individuals and their families, leaving a devastating […]

(3/3) The I3LUNG European project has officially started!

After the summary done for the first day of the kick-off, let’s dive into the second and last day of […]

(2/3) The I3LUNG European project has officially started!

As mentioned in our previous article, the kick-off meeting on July 1-2 officially started the EU I3LUNG Project. Let’s dive […]

(1/3) The I3LUNG European project has officially started!

I3LUNG is a collaborative, 5-year, 10M€ EU-funded project aiming to create an artificial intelligence (AI)-based personalized decision-making tool to aid both […]

PUBLICATIONS

🚨 Oral sessions are always a highlight at #WCLC2025!

Today, our #I3LUNG project was part of that spotlight as Arsela Prelaj from Fondazione IRCCS Istituto Nazionale dei Tumori di […]

I3LUNG at WCLC2025: Using AI to Predict Immunotherapy Biomarkers

On day 3 of #WCLC2025, Vanja Mišković from Politecnico di Milano presented the study: “An ensemble approach to predict three-class […]

Day 2 at WCLC 2025: Presenting our poster on early lung cancer detection

Today, our PI, Arsela Prelaj, defended our poster “Exploring the potential of multimodal cough analysis as a pre-screening tool for […]

#ASCO25: Giving Lung Cancer a New Voice with AI and Acoustic Biomarkers

What if your voice could help detect lung cancer? 🫁 That’s the question Chiara Giangregorio of Politecnico di Milano asked […]

📢 I3LUNG was present at the Annual Meeting of the American Association for Cancer Research (#AACR2025), held from May 25 to 30 in Chicago.

Dr. Sabina Sangaletti from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano presented the poster “Unmasking host immune complexity: single-cell […]

Empowering lung cancer patients with decision aids, by our partner IEO

· Decision aids enhance shared decision-making, reduce anxiety, and improve understanding of treatment options. · Patients value personalized support and […]

2025: We are starting strong!

Our manuscript “Cost-effectiveness models of non–small cell lung cancer: A systematic literature review” is now available in the Journal of […]

ISPOR 2024

Michael Willis, from the IHE – The Swedish Institute for Health Economics attended the 2024ISPOR conference in Barcelona this week […]

I3LUNG at ESMO 2024

I3LUNG was featured at the ESMO – European Society for Medical Oncology, held from September 13 to 17 in Barcelona. […]

IHE present in the Journal of Managed Care & Specialty Pharmacy!

Michael Willis and his team at IHE – The Swedish Institute for Health Economics, have published a groundbreaking article in […]

I3LUNG project featured in Nature Portfolio!

I3LUNG project has been featured in Nature Portfolio, one of the world’s most prestigious scientific platforms. In this article, Arsela […]

We are proud to share our latest study in Cancer Medicine Journal

We are proud to share our latest study in Cancer Medicine journal led by our partner IEO Istituto Europeo di […]

The I3LUNG project just published in Clinical Lung Cancer

We are pleased to announce that the study design of the I3LUNG project has just been published in the journal […]